CoChat
Cited by 119

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

The Alzheimer's disease-associated C99 fragment of APP regulates cellular cholesterol trafficking

Montesinos, Jorge, Pera, Marta, Larrea, Delfina, Guardia‐Laguarta, Cristina, Agrawal, Rishi R, Velasco, Kevin R, Yun, Taekyung D, Stavrovskaya, Irina G, Xu, Yimeng, Koo, So Yeon, Snead, Amanda M, Sproul, Andrew A, Area‐Gomez, Estela · 2020 · The EMBO Journal

Abstract

The link between cholesterol homeostasis and cleavage of the amyloid precursor protein (APP), and how this relationship relates to Alzheimer's disease (AD) pathogenesis, is still unknown. Cellular cholesterol levels are regulated through crosstalk between the plasma membrane (PM), where most cellular cholesterol resides, and the endoplasmic reticulum (ER), where the protein machinery that regulates cholesterol levels resides. The intracellular transport of cholesterol from the PM to the ER is believed to be activated by a lipid‐sensing peptide(s) in the ER that can cluster PM‐derived cholesterol into transient detergent‐resistant membrane domains (DRMs) within the ER, also called the ER regulatory pool of cholesterol . When formed, these cholesterol‐rich domains in the ER maintain cellular homeostasis by inducing cholesterol esterification as a mechanism of detoxification while attenuating its de novo synthesis. In this manuscript, we propose that the 99‐aa C‐terminal fragment of APP (C99), when delivered to the ER for cleavage by γ‐secretase, acts as a lipid‐sensing peptide that forms regulatory DRMs in the ER, called mitochondria‐associated ER membranes (MAM). Our data in cellular AD models indicates that increased levels of uncleaved C99 in the ER, an early phenotype of the disease, upregulates the formation of these transient DRMs by inducing the internalization of extracellular cholesterol and its trafficking from the PM to the ER. These results suggest a novel role for C99 as a mediator of cholesterol disturbances in AD, potentially explaining early hallmarks of the disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.15252/embj.2019103791

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Research works printed but not linked: 49

  1. Area‐Gomez E, de Groof AJ, Boldogh I, Bird TD, Gibson GE, Koehler CM, Yu WH, Duff KE, Yaffe MP, Pon LA et al (2009) Presenilins are enriched in endoplasmic reticulum membranes associated with mitochondria. Am J Pathol 175: 1810–1816 · DOI · Paper page
  2. Area‐Gomez E (2014) Assessing the function of mitochondria‐associated ER membranes. Methods Enzymol 547: 181–197 · DOI
  3. Barrett PJ, Song Y, Van Horn WD, Hustedt EJ, Schafer JM, Hadziselimovic A, Beel AJ, Sanders CR (2012) The amyloid precursor protein has a flexible transmembrane domain and binds cholesterol. Science 336: 1168–1171 · DOI · Paper page
  4. Beel AJ, Mobley CK, Kim HJ, Tian F, Hadziselimovic A, Jap B, Prestegard JH, Sanders CR (2008) Structural studies of the transmembrane C‐terminal domain of the amyloid precursor protein (APP): does APP function as a cholesterol sensor? Biochemistry 47: 9428–9446 · DOI · Paper page
  5. Beel AJ, Sakakura M, Barrett PJ, Sanders CR (2010) Direct binding of cholesterol to the amyloid precursor protein: an important interaction in lipid‐Alzheimer's disease relationships? Biochim Biophys Acta 1801: 975–982 · DOI · Paper page
  6. Bindesboll C, Aas A, Ogmundsdottir MH, Pankiv S, Reine T, Zoncu R, Simonsen A (2020) NBEAL1 controls SREBP2 processing and cholesterol metabolism and is a susceptibility locus for coronary artery disease. Sci Rep 10: 4528 · DOI
  7. Brown MS, Goldstein JL (1999) A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood. Proc Natl Acad Sci USA 96: 11041–11048 · DOI · Paper page
  8. Chang TY, Chang CC, Ohgami N, Yamauchi Y (2006) Cholesterol sensing, trafficking, and esterification. Annu Rev Cell Dev Biol 22: 129–157 · DOI · Paper page
  9. Chang TY, Li BL, Chang CC, Urano Y (2009) Acyl‐coenzyme A:cholesterol acyltransferases. Am J Physiol Endocrinol Metab 297: E1–E9 · DOI · Paper page
  10. Cordy JM, Hooper NM, Turner AJ (2006) The involvement of lipid rafts in Alzheimer's disease. Mol Membr Biol 23: 111–122 · DOI · Paper page
  11. Cossec JC, Simon A, Marquer C, Moldrich RX, Leterrier C, Rossier J, Duyckaerts C, Lenkei Z, Potier MC (2010) Clathrin‐dependent APP endocytosis and Abeta secretion are highly sensitive to the level of plasma membrane cholesterol. Biochim Biophys Acta 1801: 846–852 · DOI
  12. Das A, Brown MS, Anderson DD, Goldstein JL, Radhakrishnan A (2014) Three pools of plasma membrane cholesterol and their relation to cholesterol homeostasis. Elife 3: e02882 · DOI · Paper page
  13. Del Prete D, Suski JM, Oules B, Debayle D, Gay AS, Lacas‐Gervais S, Bussiere R, Bauer C, Pinton P, Paterlini‐Brechot P et al (2017) Localization and processing of the amyloid‐beta protein precursor in mitochondria‐associated membranes. J Alzheimers Dis 55: 1549–1570 · DOI · Paper page
  14. DelBove CE, Strothman CE, Lazarenko RM, Huang H, Sanders CR, Zhang Q (2019) Reciprocal modulation between amyloid precursor protein and synaptic membrane cholesterol revealed by live cell imaging. Neurobiol Dis 127: 449–461 · DOI
  15. Dong HK, Gim JA, Yeo SH, Kim HS (2017) Integrated late onset Alzheimer's disease (LOAD) susceptibility genes: cholesterol metabolism and trafficking perspectives. Gene 597: 10–16 · DOI
  16. Endapally S, Frias D, Grzemska M, Gay A, Tomchick DR, Radhakrishnan A (2019) Molecular discrimination between two conformations of sphingomyelin in plasma membranes. Cell 176: 1040–1053 · DOI · Paper page
  17. Epand RF, Thomas A, Brasseur R, Vishwanathan SA, Hunter E, Epand RM (2006) Juxtamembrane protein segments that contribute to recruitment of cholesterol into domains. Biochemistry 45: 6105–6114 · DOI
  18. Goedert M, Spillantini MG (2006) A century of Alzheimer's disease. Science 314: 777–781 · DOI · Paper page
  19. Guardia‐Laguarta C, Area‐Gomez E, Rub C, Liu Y, Magrane J, Becker D, Voos W, Schon EA, Przedborski S (2014) alpha‐Synuclein is localized to mitochondria‐associated ER membranes. J Neurosci 34: 249–259 · DOI · Paper page
  20. Hayashi T, Fujimoto M (2010) Detergent‐resistant microdomains determine the localization of sigma‐1 receptors to the endoplasmic reticulum‐mitochondria junction. Mol Pharmacol 77: 517–528 · DOI · Paper page
  21. Herms J, Anliker B, Heber S, Ring S, Fuhrmann M, Kretzschmar H, Sisodia S, Muller U (2004) Cortical dysplasia resembling human type 2 lissencephaly in mice lacking all three APP family members. EMBO J 23: 4106–4115 · DOI · Paper page
  22. Herreman A, Serneels L, Annaert W, Collen D, Schoonjans L, De Strooper B (2000) Total inactivation of γ‐secretase activity in presenilin‐deficient embryonic stem cells. Nat Cell Biol 2: 461–462 · DOI · Paper page
  23. Hu K, Yu J, Suknunllrn K, Tian S, Montgomery K, Choi KD, Stewnrt R, Thomson JA, Slukvin II (2011) Efficient generation oftransgene‐frec induced pluripotent stem cells from nonnal and neoplastic bone marrow and cord blood mononuclear cells. Blood 117: e109–e119 · DOI · Paper page
  24. Hulce JJ, Cognetta AB, Niphakis MJ, Tully SE, Cravatt BF (2013) Proteome‐wide mapping of cholesterol‐interacting proteins in mammalian cells. Nat Methods 10: 259–264 · DOI · Paper page
  25. Infante RE, Radhakrishnan A (2017) Continuous transport of a small fraction of plasma membrane cholesterol to endoplasmic reticulum regulates total cellular cholesterol. Elife 6: e25466 · DOI · Paper page
  26. Jiang Y, Mullaney KA, Peterhoff CM, Che S, Schmidt SD, Boyer‐Boiteau A, Ginsberg SD, Cataldo AM, Mathews PM, Nixon RA (2010) Alzheimer's‐related endosome dysfunction in Down syndrome is Abeta‐independent but requires APP and is reversed by BACE‐1 inhibition. Proc Natl Acad Sci USA 107: 1630–1635 · DOI · Paper page
  27. Lange Y, Ye J, Rigney M, Steck TL (1999) Regulation of endoplasmic reticulum cholesterol by plasma membrane cholesterol. J Lipid Res 40: 2264–2270 · DOI · Paper page
  28. Lauwers E, Goodchild R, Verstreken P (2016) Membrane lipids in presynaptic function and disease. Neuron 90: 11–25 · DOI · Paper page
  29. Litvinov DY, Savushkin EV, Dergunov AD (2018) Intracellular and plasma membrane events in cholesterol transport and homeostasis. J Lipids 2018: 3965054 · DOI
  30. Makar RS, Lipsky PE, Cuthbert JA (2000) Multiple mechanisms, independent of sterol regulatory element binding proteins, regulate low density lipoprotein gene transcription. J Lipid Res 41: 762–774 · DOI
  31. Marquer C, Devauges V, Cossec JC, Liot G, Lecart S, Saudou F, Duyckaerts C, Leveque‐Fort S, Potier MC (2011) Local cholesterol increase triggers amyloid precursor protein‐Bace1 clustering in lipid rafts and rapid endocytosis. FASEB J 25: 1295–1305 · DOI · Paper page
  32. Marquer C, Laine J, Dauphinot L, Hanbouch L, Lemercier‐Neuillet C, Pierrot N, Bossers K, Le M, Corlier F, Benstaali C et al (2014) Increasing membrane cholesterol of neurons in culture recapitulates Alzheimer's disease early phenotypes. Mol Neurodegener 9: 60 · DOI
  33. Montesinos J, Area‐Gomez E, Schlame M (2020) Analysis of phospholipid synthesis in mitochondria. Methods Cell Biol 155: 321–335 · DOI
  34. Newman M, Wilson L, Verdile G, Lim A, Khan I, Moussavi Nik SH, Pursglove S, Chapman G, Martins RN, Lardelli M (2014) Differential, dominant activation and inhibition of Notch signalling and APP cleavage by truncations of PSEN1 in human disease. Hum Mol Genet 23: 602–617 · DOI
  35. Palmer CP, Mahen R, Schnell E, Djamgoz MB, Aydar E (2007) Sigma‐1 receptors bind cholesterol and remodel lipid rafts in breast cancer cell lines. Cancer Res 67: 11166–11175 · DOI
  36. Pera M, Larrea D, Guardia‐Laguarta C, Montesinos J, Velasco KR, Agrawal RR, Xu Y, Chan RB, Di Paolo G, Mehler MF et al (2017) Increased localization of APP‐C99 in mitochondria‐associated ER membranes causes mitochondrial dysfunction in Alzheimer disease. EMBO J 36: 3356–3371 · DOI · Paper page
  37. Petrov AM, Kasimov MR, Zefirov AL (2016) Brain cholesterol metabolism and its defects: linkage to neurodegenerative diseases and synaptic dysfunction. Acta Naturae 8: 58–73 · DOI · Paper page
  38. Pierrot N, Tyteca D, D'Auria L, Dewachter I, Gailly P, Hendrickx A, Tasiaux B, Haylani LE, Muls N, N'Kuli F et al (2013) Amyloid precursor protein controls cholesterol turnover needed for neuronal activity. EMBO Mol Med 5: 608–625 · DOI
  39. Pulina MV, Hopkins M, Haroutunian V, Greengard P, Bustos V (2020) C99 selectively accumulates in vulnerable neurons in Alzheimer's disease. Alzheimers Dement 16: 273–282 · DOI
  40. Skaper SD, Facci L (2018) Culture of neonatal rodent microglia, astrocytes, and oligodendrocytes from the cortex, spinal cord, and cerebellum. Methods Mol Biol 1727: 49–61 · DOI
  41. Slotte JP, Bierman EL (1988) Depletion of plasma‐membrane sphingomyelin rapidly alters the distribution of cholesterol between plasma membranes and intracellular cholesterol pools in cultured fibroblasts. Biochem J 250: 653–658 · DOI · Paper page
  42. Sun J, Carlson‐Stevermer J, Das U, Shen M, Delenclos M, Snead AM, Koo SY, Wang L, Qiao D, Loi J et al (2019) CRISPR/Cas9 editing of APP C‐terminus attenuates beta‐cleavage and promotes alpha‐cleavage. Nat Commun 10: 53 · DOI · Paper page
  43. Tamayev R, Matsuda S, Arancio O, D'Adamio L (2012) beta‐ but not gamma‐secretase proteolysis of APP causes synaptic and memory deficits in a mouse model of dementia. EMBO Mol Med 4: 171–179 · DOI · Paper page
  44. Vance JE (2014) MAM (mitochondria‐associated membranes) in mammalian cells: lipids and beyond. Biochim Biophys Acta 1841: 595–609 · DOI · Paper page
  45. Wahrle S, Das P, Nyborg AC, McLendon C, Shoji M, Kawarabayashi T, Younkin LH, Younkin SG, Golde TE (2002) Cholesterol‐dependent gamma‐secretase activity in buoyant cholesterol‐rich membrane microdomains. Neurobiol Dis 9: 11–23 · DOI · Paper page
  46. Wang W, Mutka AL, Zmrzljak UP, Rozman D, Tanila H, Gylling H, Remes AM, Huttunen HJ, Ikonen E (2014) Amyloid precursor protein alpha‐ and beta‐cleaved ectodomains exert opposing control of cholesterol homeostasis via SREBP2. FASEB J 28: 849–860 · DOI
  47. Yu C, Alterman M, Dobrowsky RT (2005) Ceramide displaces cholesterol from lipid rafts and decreases the association of the cholesterol binding protein caveolin‐1. J Lipid Res 46: 1678–1691 · DOI
  48. Yu J, Vodyanik MA, Smuga‐Otto K, Antosiewicz‐Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, et al. (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318: 1917–1920 · DOI · Paper page
  49. Zhang X, Herrmann U, Weyer SW, Both M, Muller UC, Korte M, Draguhn A (2013) Hippocampal network oscillations in APP/APLP2‐deficient mice. PLoS ONE 8: e61198 · DOI

Cited by

See all 119

Metadata

Authors
Montesinos, J., Pera, M., Larrea, D., Guardia‐Laguarta, C., Agrawal, R. R., Velasco, K. R., Yun, T. D., Stavrovskaya, I. G., Xu, Y., Koo, S. Y., Snead, A. M., Sproul, A. A., & Area‐Gomez, E.
Venue
The EMBO Journal
Published
2020-08-31
Volume
39
Issue
20
ISSN
  • 0261-4189
  • 1460-2075
Cited by
119
References
15
Language
en
Licence
Funders
  • National Institutes of Health (K01-AG045335, R01-AG056387-01)
  • Alzheimer's Association (AARF-19-614721)
  • Michael J Fox Foundation
  • Leir Foundation
  • Henry and Marilyn Taub Foundation
  • DOD | National Defense Science and Engineering Graduate (NDSEG) Fellowship (FA9550-11-C-0028)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Alzheimer's disease-associated C99 fragment of APP regulates cellular cholesterol trafficking. https://app.cochat.ai/papers/10.15252/embj.2019103791
The paper
Montesinos, J., Pera, M., Larrea, D., Guardia‐Laguarta, C., Agrawal, R. R., Velasco, K. R., Yun, T. D., Stavrovskaya, I. G., Xu, Y., Koo, S. Y., Snead, A. M., Sproul, A. A., & Area‐Gomez, E. (2020). The Alzheimer's disease-associated C99 fragment of APP regulates cellular cholesterol trafficking. The EMBO Journal. https://doi.org/10.15252/embj.2019103791

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.